Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Franklin Genomic Advancements ETF (NY: HELX )

32.37 +0.48 (+1.51%)
Official Closing Price Updated: 4:10 PM EDT, Sep 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

2005 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
July 20, 2005
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
April 28, 2005
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
March 15, 2005

2004 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
October 21, 2004
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
July 21, 2004
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
April 28, 2004
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
January 29, 2004

2003 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
October 19, 2003
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
July 20, 2003
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
April 16, 2003
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
January 29, 2003

2002 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
October 17, 2002
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
July 17, 2002
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
April 29, 2002
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
February 20, 2002

2001 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
October 29, 2001
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
August 01, 2001
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
May 08, 2001
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
March 27, 2001
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.